Latest features

Most popular

CPD Articles


  • New toxin accepted for review

    Biopharmaceutical company Hugel America and aesthetic manufacturer Croma-Pharma has unveiled that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for letibotulinumtoxinA as a treatment for glabellar lines.

  • On the Scene: Success In Aesthetic Business

    The first Success In Aesthetic Business (SIAB) meeting was held at the Crowne Plaza in Solihull on June 4.


    • No matching jobs were found.